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journal homepage: www.j fda-onl ine.comEditorialIntroduction to the Special Issue: Promoting global
healtheTreatment and prevention of substance
abuse and HIV in AsiaThis special issue documents the first meeting of the biennial
Conference Series to Promote Global Health, which was held
on April 17e19, 2013, in Taipei, Taiwan. The conference series
is sponsored by the National Institute on Drug Abuse of the US
National Institutes of Health, and the first meeting was orga-
nized by the UCLA Center for Advancing Longitudinal Drug
Abuse Research (CALDAR), the Taiwan National Health
Research Institute (NHRI), and the Taiwan Food and Drug
Administration (TFDA). The theme of the first conference was
prevention and treatment of substance abuse and human
immunodeficiency virus (HIV) infection, focusing on Asia and
the Pacific Islands (API).
Articles in this special issue are organized into three sec-
tions. Section 1 consists of nine articles providing highlights
from selected conference sessions. Section 2 includes five
articles describing the current status of drug abuse and HIV in
five Asian countries (China, Japan, Malaysia, Taiwan, and
Vietnam) reported by their representatives. Section 3 has 15
articles, with the first 14 based on individual presentations at
the conference. The final article summarizes priority research
topics generated by workgroups, which will form the basis for
planning future international collaborative research on the
prevention and treatment of substance use and HIV infection,
in order to promote health in API and other populations.
Drug use persists as amajor problem that severely impacts
the health of individuals and populations, both locally and
globally. The international Conference Series to Promote
Global Health is designed to promote the sharing of research
findings on substance abuse treatment and HIV prevention,stimulate international collaborations, particularly between
the United States and API countries, and inform cultural as-
pects of the treatment and prevention of substance abuse and
HIV infection. These and upcoming activities are part of the
efforts to promulgate research-based interventions to
improve health services and promote health globally.
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